JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3905 Valspodar

Summary: P-glycoprotein inhibitor

insoluble in H2O; ≥15.77 mg/mL
A4451 Deguelin

Summary: Anticancer and antiviral agent

Soluble in DMSO
A4527 DR 2313

Summary: PARP inhibitor

≥83.33 mg/mL
A4482 Pifithrin-μ
1 Citation

Target: Autophagy|p53|HSP70

Summary: Inhibitor of p53 binding and anti-apoptotic

insoluble in H2O; ≥18.1 mg/mL
A3969 Vatalanib
1 Citation

Target: VEGFR

Summary: VEGFR-1/-2 inhibitor,cell-permeable

≥16.85 mg/mL
A5112 XL147

Target: PI3K

Summary: PI3K inhibitor,selective and reversible

≥22.45 mg/mL
A5133 Irinotecan
1 Citation

Summary: Topoisomerase I inhibitor

insoluble in H2O; ≥11.4 mg/mL
A5424 Fludarabine
3 Citation

Summary: DNA synthsis inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
A5459 PHA-793887
1 Citation

Target: Cyclin-Dependent Kinases

Summary: Pan-Cdk inhibitor

insoluble in H2O; ≥18.05 mg/mL
A5801 BIX 02189

Target: MEK|ERK

Summary: Selective MEK5 inhibitor

≥22.05 mg/mL